Showing results (161-170 of 203) with videos related to

Sort By:
Pageof 21
Plos One|September 25, 2018
Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer CenterTamer M Fouad, Naoto T Ueno, Robert K Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2013
Uncovering the molecular secrets of inflammatory breast cancer biology: an integrated analysis of three distinct affymetrix gene expression datasetsSteven J Van Laere, Naoto T Ueno, Pascal Finetti, et al.
Breast Cancer Research and Treatment|March 7, 2012
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body massHenry M Kuerer, Sara A Lari, Banu K Arun, et al.
Annals of Surgical Oncology|August 27, 2013
Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?Elizabeth Fitzsullivan, Sara A Lari, Benjamin Smith, et al.
Molecular Cancer|July 10, 2010
Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsBisrat G Debeb, Xiaomei Zhang, Savitri Krishnamurthy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 18, 2015
C-reactive protein as a marker of melanoma progressionShenying Fang, Yuling Wang, Dawen Sui, et al.
Annals of Surgical Oncology|May 25, 2012
Biology, treatment, and outcome in very young and older women with DCISRosalinda Alvarado, Sara A Lari, Robert E Roses, et al.
International Journal of Cancer|September 9, 2014
The relationship between blood IL-12p40 level and melanoma progressionShenying Fang, Yuling Wang, Yun Shin Chun, et al.
Therapeutic Advances in Medical Oncology|October 21, 2025
A phase Ib/II trial of neoadjuvant neratinib added to standard therapy in patients with HER2-positive or HR-positive/HER2-negative inflammatory breast cancer (including stage III and IV disease)Bora Lim, Angela Marx, Megumi Kai, et al.
The Journal of Investigative Dermatology|April 8, 2015
Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and OutcomesShenying Fang, Yuling Wang, Yun S Chun, et al.
Pageof 21